Literature DB >> 9237103

Elevated expression of Bcl-2 and Bcl-x by intestinal intraepithelial lymphocytes: resistance to apoptosis by glucocorticoids and irradiation.

N Van Houten1, S F Blake, E J Li, T A Hallam, D G Chilton, W K Gourley, L H Boise, C B Thompson, E B Thompson.   

Abstract

Administration of glucocorticoids or exposure to ionizing radiation in vivo results in a rapid cell death of thymocytes. We report that murine small intestinal intraepithelial lymphocytes (IEL) are resistant to both steroid- and radiation-induced deletion. This is due to resistance to apoptosis, as evidenced by the absence of detectable apoptotic IEL nuclei in situ after in vivo glucocorticoid treatment. IEL express normal levels of glucocorticoid receptors and these receptors bind [3H]dexamethasone to equivalent levels as other lymphocyte populations. Thus, their survival is due to post-receptor signaling mechanisms. Many IEL express high levels of Bcl-2 and that of these Bcl-2high IEL are largely TCR gamma delta +. Those IEL that do express high levels of Bcl-2 are CD8 alpha + beta - CD4-. In addition, IEL express Bcl-x, another protein shown to be involved in the protection of cells from apoptotic signals. IEL represent the first lymphocyte population in vivo shown to have high levels of expression of both molecules, that otherwise occur only in activated lymphocytes in vitro. These data suggest that the Bcl-2+Bcl-x+ IEL are activated cells and not an effete population of cells necessarily destined to die. Also, the high levels of Bcl-2 and Bcl-x in this in vivo activated population supports the in vitro correlate of protection from activation-induced cell death.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9237103     DOI: 10.1093/intimm/9.7.945

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  9 in total

1.  Suppression of radiation-induced testicular germ cell apoptosis by 2,5-hexanedione pretreatment. III. Candidate gene analysis identifies a role for fas in the attenuation of X-ray-induced apoptosis.

Authors:  Sarah N Campion; Moses A Sandrof; Hideki Yamasaki; Kim Boekelheide
Journal:  Toxicol Sci       Date:  2010-07-08       Impact factor: 4.849

2.  Rifampicin inhibits CD95-mediated apoptosis of Jurkat T cells via glucocorticoid receptors by modifying the expression of molecules regulating apoptosis.

Authors:  Rama Yerramasetti; Sastry Gollapudi; Sudhir Gupta
Journal:  J Clin Immunol       Date:  2002-01       Impact factor: 8.317

3.  The Proto-oncogene PKCι regulates the alternative splicing of Bcl-x pre-mRNA.

Authors:  Jacqueline C Shultz; Ngoc Vu; Michael D Shultz; Mba-Uzoma U Mba; Brian A Shapiro; Charles E Chalfant
Journal:  Mol Cancer Res       Date:  2012-04-20       Impact factor: 5.852

4.  Quantitative analysis of BCL2 mRNA expression in nasopharyngeal carcinoma: an unfavorable and independent prognostic factor.

Authors:  Ali Fendri; Christos K Kontos; Abdelmajid Khabir; Raja Mokdad-Gargouri; Alexandros Ardavanis; Andreas Scorilas
Journal:  Tumour Biol       Date:  2010-06-01

5.  Crosstalk pathway for inhibition of glucocorticoid-induced apoptosis by T cell receptor signaling.

Authors:  C A Jamieson; K R Yamamoto
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

Review 6.  Proteins of multiple classes may participate in nongenomic steroid actions.

Authors:  Cheryl S Watson; Bahiru Gametchu
Journal:  Exp Biol Med (Maywood)       Date:  2003-12

7.  High- and low-affinity single-peptide/MHC ligands have distinct effects on the development of mucosal CD8alphaalpha and CD8alphabeta T lymphocytes.

Authors:  C N Levelt; Y P de Jong; E Mizoguchi; C O'Farrelly; A K Bhan; S Tonegawa; C Terhorst; S J Simpson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

Review 8.  Tissue-selective therapy of cancer.

Authors:  M V Blagosklonny
Journal:  Br J Cancer       Date:  2003-10-06       Impact factor: 7.640

9.  Origin, trafficking, and intraepithelial fate of gut-tropic T cells.

Authors:  Delphine Guy-Grand; Pierre Vassalli; Gerard Eberl; Pablo Pereira; Odile Burlen-Defranoux; Fabrice Lemaitre; James P Di Santo; Antonio A Freitas; Ana Cumano; Antonio Bandeira
Journal:  J Exp Med       Date:  2013-08-05       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.